SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEMASURE (HMSR) - Buyout in the works?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bruce bell who wrote (26)12/2/1997 8:34:00 AM
From: hcm1943  Read Replies (3) of 88
 
1) Smith B dropped coverage yesterday when anal ist who covered it was terminated "due to merger with Solomon" (this is what I heard)
2) the Novo deal is what caused the hugh writedown when the linked deal with Upjohn didn't go through ( hmsr settled with UPJ for 2.5mil)
and is still attempting to sell the Novo facility.
3) I won't telll you to add to your position, but in my opinion there is far more upside than down at this point, and I think in January when the debt becomes equity at 10 1/2 per sh HMSRs balance sheet will improve enough to seek relisting save for the minimum price requirements which by that time I feel will not be an issue
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext